SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Bringing together the academic drug discovery community
1 references·5 citing·22 second hop
Bringing together the academic drug discovery community (2013)Bringing together the academic drug disco…How to improve R&D productivity: the pharmaceutical industry's grand challenge (2010)How to improve R&D productivi…Trait and state biomarkers for psychiatric disorders: Importance of infrastructure to bridge the gap between basic and clinical research and industry (2018)Trait and state biomarkers fo…The academic–industrial complex: navigating the translational and cultural divide (2017)The academic–industrial compl…Open for collaboration: an academic platform for drug discovery and development at SciLifeLab (2016)Open for collaboration: an ac…Open innovation in early drug discovery: roadmaps and roadblocks (2015)Open innovation in early drug…Academic–Industrial Collaboration: Toward the Consilience of Two Solitudes (2015)Academic–Industrial Collabora…A Proof for the Queuing Formula: L = λ W (1961)The Goal: A Process of Ongoing Improvement (1984)Can the pharmaceutical industry reduce attrition rates? (2004)Diagnosing the decline in pharmaceutical R&D efficiency (2012)Innovation in the pharmaceutical industry: New estimates of R&D costs (2016)Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018 (2020)Open Innovation: The New Imperative for Creating and Profiting from Technology (2003)The Era of Open Innovation (2003)Measuring the effectiveness and impact of an open innovation platform (2017)Diving into the uncertainties of open innovation: A systematic review of risks to uncover pertinent typologies and unexplored horizons (2022)Collaborative innovation during the drug discovery and development process (2025)Lessons from 60 years of pharmaceutical innovation (2009)The cost of drug development: A systematic review (2011)The Role of Public-Sector Research in the Discovery of Drugs and Vaccines (2011)The importance of new companies for drug discovery: origins of a decade of new drugs (2010)Believe it or not: how much can we rely on published data on potential drug targets? (2011)Open innovation in neuroscience research and drug discovery (2018)Doing science together: Gaining momentum from long-term explorative university–industry research programs (2023)HARKing: Hypothesizing After the Results are Known (1998)Development and validation of a brief screening version of the Childhood Trauma Questionnaire (2003)Research Domain Criteria (RDoC): Toward a New Classification Framework for Research on Mental Disorders (2010)Diagnostic and Statistical Manual of Mental Disorders (2013)
this work references cited by second hop

References

  • 2010How to improve R&D productivity: the pharmaceutical industry's grand challenge3,562 cited

Cited by

  • 2018Trait and state biomarkers for psychiatric disorders: Importance of infrastructure to bridge the gap between basic and clinical research and industry35 cited
  • 2015Open innovation in early drug discovery: roadmaps and roadblocks32 cited
  • 2017The academic–industrial complex: navigating the translational and cultural divide16 cited
  • 2016Open for collaboration: an academic platform for drug discovery and development at SciLifeLab13 cited
  • 2015Academic–Industrial Collaboration: Toward the Consilience of Two Solitudes9 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work